Skip to content
value.today
Amarin Corp PLC\UK logo

Amarin Corp PLC\UK

PharmaceuticalsFounded 1993amarincorp.com

Formerly Lockgen Limited

Total raised
$70 M
1 round on record
Latest round
$70 M
Oct 2009
First round on record
Oct 2009
Today
Went public
See the company page

Amarin Corp PLC\UK is listed today as Amarin Corporation: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Amarin Corp PLC\UK
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2009$70 MNo. 1$50 to $250 million

Amarin Corp PLC\UK: Raise no. 1, Oct 2009

Investors in this round

36 investors had bought by the notice of Oct 30, 2009: 36 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$70 M of $70 M offered
Smallest investment taken
$50,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$1,300,000
Finders' fees
$510,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in United Kingdom

People named in the notice

  • Alan L. Cooke · Executive Officer · CFO
  • Thomas G. Lynch · Executive Officer, Director · Chief Executive Officer and Chairman
  • Carl L. Gordon · Director
  • James I. Healy · Director
  • Joseph L. Anderson · Director
  • Lars L. Ekman · Director
  • Manus L. Rogan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Cowen and Company LLC (CRD 1716) · New York, NySold in no state named

Signed by Alan Cooke, Cfo. Source: SEC Form D, newest notice filed Oct 30, 2009. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Amarin Corporation, its revenue in fiscal 2025 came from these product and service lines: Licensing and Royalty Revenue $30.89 million (14%).

    Annual report (SEC XBRL) · Dec 2025

  • Amarin Corp PLC\UK had no revenue when it filed its newest notice of a funding round (Oct 2009).

    SEC Form D (revenue range) · Oct 2009

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Oct 2009

Products and services#

No products or services of Amarin Corp PLC\UK are on record.

Investors#

No investor of Amarin Corp PLC\UK is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 36 investors.

Largest shareholders today

Institutions holding Amarin Corporation shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Amarin Corp PLC\UK
NameRoleNamed in
Alan L. CookeCFOOct 2009
Thomas G. LynchChief Executive Officer and ChairmanOct 2009
Carl L. GordonDirectorOct 2009
James I. HealyDirectorOct 2009
Joseph L. AndersonDirectorOct 2009
Lars L. EkmanDirectorOct 2009
Manus L. RoganDirectorOct 2009
Thomas G. LynchChief Executive Officer and ChairmanOct 2009

About

Biopharmaceutical company.

Went public since 2011. Its SEC number is that of a company listed on a stock exchange.